维普中文期刊产品整合服务
20篇 您的检索式:作者名="Guffon"
    题名 作者 年代 出处 被引量
1Safety and efficacy of recombinant human α-galactosidase A-replacement therapy in Fabry's disease显示文摘Eng CM Guffon N Wilcox WR 2001N Engl J Med2001,345,1:1
2Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stern cell sourees 显示文摘Souillet G Guffon N Maire I 2003Bone Marrow Transplant2003,31,12:1
3Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources 显示文摘Souillet G Guffon N Maire I 2003Bone Marrow Transplant2003,31,12:1
4Long-term safety and efficacy of enzyme replacement therapy for Fabry disease显示文摘Wilcox WR Banikazemi M Guffon N 2004Am J Hum Genet2004,75,1:1
5Mucopolysaccharidosls type Ⅱ-genotype/phenotype aspects 显示文摘FROISSART R MOREIRA DA SILVA I GUFFON N 2002Acta Paediatr Suppl2002,91,439:1
6Safety and efficacy of recombinant human o-galactosidase A replacement therapy in fabry 's disease 显示文摘Eng CM Guffon N Wilcox WR 2001N Engl J Med2001,345,:1
7A new neonatal case of N-acetylglutamate syn- thase deficiency treated by carbamylglutamate 显示文摘GUFFON N VIANEY-SABAN C BOURGEOIS J 1995Journal of Inherited Metabolic Disease1995,18,1:1
8Clinical presentation in female patients with Fabry disease显示文摘Guffon N 2003J Med Genet2003,40,4:1
9Outcome of 27 patients with Hurler′s syndrome transp lanted from either related or unrelated haematopoietic stem cell sources显示文摘Souillet G Guffon N Maire I 0,,12:1
10Safety and efficacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry's disease显示文摘 Guffon N Wilcox WR 2001N Engl J Med2001,345,:1
11Natural history of Niemann-Pick disease type C in a multicentre observational retrospective cohort study显示文摘Wraith JE Guffon N Rohrbach M 2009Mol Genet Metab2009,98,:1
12Safety and efficacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry's disease显示文摘Eng CM Guffon N Wilcox WR 2001N Engl J Med2001,345,:1
13Long-term safety and efficacy of enzyme replacement therapy for Fabry disease显示文摘Wilcox WR Banikazemi M Guffon N 2004Am J Hum Genet2004,75,1:1
14Long-term safetv and efficacy of enzyme replacement therapy for Fabry disease显示文摘Wilcox WR Banikazemi M Guffon N 2004Am J Hum Genet2004,75,1:1
15Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources显示文摘Souillet G Guffon N Maire I Pujol M Taylor P Sevin F 2003Bone Marrow Transplant2003,31,12:1
16Long-term safety and efficacy of enzyme replacement therapy for Fabry disease显示文摘Wilcox WR Banikazemi M Guffon N 2004Am J Hum Genet2004,75,1:1
17Safety and efficacy of recombinant human ot-galactosidase A: replacement therapy in Fabry's disease显示文摘Eng CM Guffon N Wilcox WR 2001N Engl J Med2001,345,1:1
18A new neonatal case of N-acetylglutamate synthase deficiency treated by earbamylglutamate显示文摘Guffon N Vianey-Saban C Bourgeois J 1995J Inherit Metab Dis1995,,18:1
19Long-term safety and eftieacy of enzyme replacement therapy for Fabry disease显示文摘Wilcox WR Banikazemi M Guffon N 2004Am J Hum Genet2004,75,1:1
20N-氨甲酰基-L-谷氨酸测试新生儿高氨血症显示文摘In a prospective study, patients with a suspected urea cycle defect underwent oral N-carbamoyl-L-glutamic acid loading testing. In patients with subsequent ly confirmed N-acetyl-gltamate synthase deficiency, hyperammonemia normalized within 8 hours. This t est may be useful in the early diagnosis of patients with suspected urea cycle d isorders.Guffon N. Schiff M. Cheillan D. 贺文龙 2006世界核心医学期刊文摘(儿科学分册)2006,0,1:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费